John Kirk - Net Worth and Insider Trading
John Kirk Net Worth
The estimated net worth of John Kirk is at least $64,206 dollars as of 2024-09-21. John Kirk is the VP, Regulatory Affairs of Amicus Therapeutics Inc and owns about 5,687 shares of Amicus Therapeutics Inc (FOLD) stock worth over $64,206. Details can be seen in John Kirk's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Kirk has not made any transactions after 2015-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Kirk
John Kirk Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Kirk owns 1 companies in total, including Amicus Therapeutics Inc (FOLD) .
Click here to see the complete history of John Kirk’s form 4 insider trades.
Insider Ownership Summary of John Kirk
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2015-05-11 | VP & Regulatory Affairs |
John Kirk Latest Holdings Summary
John Kirk currently owns a total of 1 stock. John Kirk owns 5,687 shares of Amicus Therapeutics Inc (FOLD) as of May 11, 2015, with a value of $64,206.
Latest Holdings of John Kirk
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2015-05-11 | 5,687 | 11.29 | 64,206 |
Holding Weightings of John Kirk
John Kirk Form 4 Trading Tracker
According to the SEC Form 4 filings, John Kirk has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 10,000 shares on May 11, 2015, which brought John Kirk around $108,400.
Insider Trading History of John Kirk
- 1
John Kirk Trading Performance
John Kirk Ownership Network
John Kirk Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
John Kirk is the VP & Regulatory Affairs of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, John Kirk made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 351,367 shares made by John F Crowley , a net sale of 233,261 shares made by Bradley L Campbell , and a net sale of 95,000 shares made by Ellen Rosenberg .
In summary, during the past 3 months, insiders sold 22,500 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 22,500 shares. During the past 18 months, 822,412 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 822,412 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
John Kirk Mailing Address
Above is the net worth, insider trading, and ownership report for John Kirk. You might contact John Kirk via mailing address: C/o Amicus Therapeutics Inc, 6 Cedar Brook Drice, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
